Urine Organic Acid Analysis: Qualitative and quantitative determination of organic acids. This test can detect lactic acid, pyruvic acid, 2-methylcitric acid, methylmalonic acid, 3-hydroxypropionic acid and propionylglycine to aid in the diagnosis of an organic acidemia associated with elevated C3 and/or C3/C2 ratio.
Acylcarnitine Profile: Plasma acylcarnitine analysis provides quantitative evaluations of individual acylcarnitine species in the plasma. Pattern recognition and quantitative analysis against age matched reference ranges can be used to identify organic acidemias that could be causative of C3 and/or C3/C2 ratio elevations on newborn screening.
Carnitine Profile: Provides plasma free, total, and esterified carnitine levels of the patient. Secondary carnitine deficiency can be seen in patients with B12 deficiency, methylmalonic acidemia or propionic aciduria.
Amino Acids Profile: Plasma amino acids analysis will detect specific amino acid disorders and some elevations of homocystine. For patients who are found to be affected with a metabolic disease, plasma amino acid analysis will provide a baseline for nutritional management.
Methylmalonic Acid: Elevated plasma methylmalonic acid can be seen in vitamin B12 deficiency, as well as several inherited forms if methylmalonic acidemia. The magnitude of elevation can be useful in the differential diagnosis, and as a baseline for monitoring treatment in an affected patient.
Homocysteine: Elevated plasma total homocysteine can be seen in combined forms of methylmalonic acidemia/homocystinuria.
This panel is offered as a comprehensive starting point for patients with an abnormal newborn screening (NBS) with elevated C3 and/or C3/C2 ratio. Patients may be asymptomatic or present with varying symptoms including lethargy, coma, hypotonia, seizures, ataxia, vomiting, failure to thrive or metabolic acidosis.
- Urine Organic Acid Analysis: Gas chromatography-mass spectrometry
- Acylcarnitine Profile: Electrospray tandem mass spectrometry
- Carnitine Profile: Electrospray tandem mass spectrometry
- Amino acid Profile: Ion exchange liquid chromatography
- Methylmalonic Acid: Liquid chromatography-electrospray tandem mass spectrometry
- Homocysteine: Liquid chromatography-electrospray tandem mass spectrometry
This panel can detect most cases of metabolic conditions that are triggered by a positive newborn screen for elevated C3 and/or C3/C2 ratio. Correlation with other laboratory tests (particularly plasma vitamin B12 levels) and the patient's clinical status at still needed. In infants, a positive newborn screen can be caused by maternal B12 deficiency, particularly in vegan mothers or those who have undergone gastric bypass surgery. Correlation with the mother's B12 levels, clinical and dietary history is also necessary in such cases.
Freeze sample. Fasting or first void sample is preferable.
Sample should be collected while fasting or 2-4 hours post prandial. Centrifuge to separate plasma and freeze. Separate plasma within 30 minutes of collection
Sample should be collected while fasting or 2-4 hours post prandial. Centrifuge to separate plasma and freeze.
Both plasma AND urine are required for this panel. Please indicate on the test requisition form any medications or dietary changes.
The components of this panel can be ordered separately when a specific metabolic condition is suspected.
- Acylcarnitine Profile, Quantitative and Qualitative, Plasma (AR), Carnitine Profile, Quantitative, Plasma (CN) and Organic Acid Profile, Quantitative and Qualitative, Urine (OA) are used in the diagnosis and evaluation of patients with organic acidemias, or fatty acid disorders.
- Amino Acid Profile, Quantitative, Plasma (AA) is used in the diagnosis and evaluation of patients with aminoacidopathies.
- Homocysteine, Total Quantitative, Plasma (HO) is used for individuals suspected to have homocystinuria, B12 deficiency, or hyperhomocyst(e)inemia.
- Methylmalonic Acid, Quantitative, Plasma (MQ) is indicated to obtain accurate methylmalonic acid measurement in the patient with methylmalonic aciduria or B12 deficiency, before and after treatment.